Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor ImmunityCancer discovery, 2017-05, Vol.7 (5), p.522-538ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.CD-16-0932Full text available |
|
2 |
Material Type: Article
|
[Retracted] MicroRNA‑329‑3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancerOncology reports, 2024-06, Vol.51 (6)Copyright Spandidos Publications UK Ltd. 2024 ;ISSN: 1021-335X ;EISSN: 1791-2431 ;DOI: 10.3892/or.2024.8745 ;PMID: 38695244Full text available |
|
3 |
Material Type: Article
|
Novel Anti-LY6G6D/CD3 T-Cell–Dependent Bispecific Antibody for the Treatment of Colorectal CancerMolecular cancer therapeutics, 2022-04, Vol.21 (6) [Peer Reviewed Journal]ISSN: 1535-7163 ;EISSN: 1538-8514Full text available |
|
4 |
Material Type: Book
|
CT Colonography for Radiographers: A Guide to Performance and Image InterpretationISBN: 9783319293776 ;ISBN: 331929377X ;EISBN: 9783319293790 ;EISBN: 3319293796 ;OCLC: 957699992Full text available |
|
5 |
Material Type: Article
|
Patient-Reported Outcomes in Pediatric Cancer Registration Trials: A US Food and Drug Administration PerspectiveJNCI : Journal of the National Cancer Institute, 2021-04, Vol.114 (1) [Peer Reviewed Journal]ISSN: 0027-8874 ;EISSN: 1460-2105Full text available |
|
6 |
Material Type: Article
|
Translating Evidence from Dutch Exercise Oncology Trials in Patients with Breast Cancer into Clinical Practice Using the RE-AIM Frameworkinfo:eu-repo/semantics/OpenAccess ;ISSN: 0961-5423 ;EISSN: 1365-2354Full text available |
|
7 |
Material Type: Article
|
Targeting IL-1β as an immunopreventive and therapeutic modality for K-ras-mutant lung cancerJCI insight, 2022-06, Vol.7 (11) [Peer Reviewed Journal]2022 Yuan et al. 2022 Yuan et al. ;ISSN: 2379-3708 ;EISSN: 2379-3708 ;DOI: 10.1172/jci.insight.157788 ;PMID: 35471938Full text available |
|
8 |
Material Type: Article
|
Retraction: A novel therapeutic strategy of combined camrelizumab and apatinib for the treatment of advanced hepatocellular carcinomaFrontiers in oncology, 2024, Vol.14, p.1383375-1383375 [Peer Reviewed Journal]Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383375 ;PMID: 38454926Full text available |
|
9 |
Material Type: Article
|
Retraction: Effects of Aidi injection on life quality and incidence of adverse reactions in patients with non-small cell lung cancer compared with traditional chemotherapy: a systematic review and meta-analysisFrontiers in oncology, 2024, Vol.14, p.1383346-1383346 [Peer Reviewed Journal]Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383346 ;PMID: 38440226Full text available |
|
10 |
Material Type: Article
|
Retraction: Overexpressed tumor suppressor exosomal miR-15a-5p in cancer cells inhibits PD1 expression in CD8+T cells and suppresses the hepatocellular carcinoma progressionFrontiers in oncology, 2024, Vol.14, p.1388383-1388383 [Peer Reviewed Journal]Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1388383 ;PMID: 38505586Full text available |
|
11 |
Material Type: Article
|
Retraction: Evaluation of the safety of retroperitoneal laparoscopic partial nephrectomy by investigating the perioperative indicatorsFrontiers in oncology, 2024, Vol.14, p.1383340-1383340 [Peer Reviewed Journal]Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383340 ;PMID: 38440232Full text available |
|
12 |
Material Type: Article
|
Retraction: Prognostic influence of PD-1/PD-L1 suppressors in combination with chemotherapeutic agents for non-small cell pulmonary carcinoma: system review and meta-analysisFrontiers in oncology, 2024, Vol.14, p.1383366-1383366 [Peer Reviewed Journal]Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383366 ;PMID: 38440228Full text available |
|
13 |
Material Type: Article
|
Retraction: The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: a retrospective analysisFrontiers in oncology, 2024, Vol.14, p.1383410-1383410 [Peer Reviewed Journal]Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383410 ;PMID: 38444679Full text available |
|
14 |
Material Type: Article
|
Retraction: A study on expression level and nutritional status of IGFBP-2 after left neck anastomosis combined with placement of feeding nutritional applicators carrying ^(125)I particles in the treatment of esophageal cancerFrontiers in oncology, 2024, Vol.14, p.1383394-1383394 [Peer Reviewed Journal]Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383394 ;PMID: 38450196Full text available |
|
15 |
Material Type: Article
|
Retraction: Meta analysis of clinical prognosis of radiofrequency ablation versus partial nephrectomy in the treatment of early renal cell carcinomaFrontiers in oncology, 2024, Vol.14, p.1383353-1383353 [Peer Reviewed Journal]Copyright © 2024 Frontiers Editorial Office. ;Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2024.1383353 ;PMID: 38444681Full text available |
|
16 |
Material Type: Article
|
Retraction: Emodin interferes with AKT1-mediated DNA damage and decreases resistance of breast cancer cells to doxorubicinFrontiers in oncology, 2023-12, Vol.13, p.1337635-1337635 [Peer Reviewed Journal]Copyright © 2023 Frontiers Editorial Office. ;Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1337635 ;PMID: 38130993Full text available |
|
17 |
Material Type: Article
|
Retraction: New insights into molecular signalling pathways and current advancements in prostate cancer diagnostics and therapeuticsFrontiers in oncology, 2023-12, Vol.13, p.1343833-1343833 [Peer Reviewed Journal]Copyright © 2023 Frontiers Editorial Office. ;Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1343833 ;PMID: 38130994Full text available |
|
18 |
Material Type: Article
|
Retraction: Long noncoding RNA LOC400043 (LINC02381) inhibits gastric cancer progression through regulating Wnt signaling pathwayFrontiers in oncology, 2023-12, Vol.13, p.1298859-1298859 [Peer Reviewed Journal]Copyright © 2023 Frontiers Editorial Office. ;Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1298859 ;PMID: 38115901Full text available |
|
19 |
Material Type: Article
|
Retraction: Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumorsFrontiers in oncology, 2023-10, Vol.13, p.1301668-1301668 [Peer Reviewed Journal]Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1301668Full text available |
|
20 |
Material Type: Article
|
Retraction: LncRNA TCF7 promotes epithelial ovarian cancer viability, mobility and stemness via regulating ITGB8Frontiers in oncology, 2023-10, Vol.13, p.1307324-1307324 [Peer Reviewed Journal]Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1307324Full text available |